Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

Bioequivalence Study of BGM0504 Injection

BrightGene Bio-Medical Technology Co · Phase 1 · Completed · Enrollment 144

NCT07382908

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
BGM0504 Injection multi-dose penn/rn/rn/rn/r
BGM0504 Injection single-dose penn/rn/rn/rn/r
BGM0504 Injection single-dose pen-2n/rn/rn/rn/r

Not shown

  • BGM0504 Injection multi-dose pen: endpoint not reported
  • BGM0504 Injection single-dose pen: endpoint not reported
  • BGM0504 Injection single-dose pen-2: endpoint not reported